Abbott Laboratories (NYSE:ABT)

62.51
Delayed Data
As of 4:00pm ET
 +0.67 / +1.08%
Today’s Change
43.40
Today|||52-Week Range
64.60
+9.53%
Year-to-Date
Abbott Labs Presents Results of Global Trial
11:15am / GuruFocus News - Paid Partner Content
Cardiovascular Systems Rides on New Products Amid Tight Race
May 22 / Zacks.com - Paid Partner Content
Abbott Gets FDA Nod for XIENCE Sierra, To Boost Vascular Wing
10:02am / Zacks.com - Paid Partner Content
Why Is Abbott (ABT) Up 2% Since Its Last Earnings Report?
May 18 / Zacks.com - Paid Partner Content
MEMBERS Trust Co Buys Marathon Petroleum Corp, iShares Russell Mid-Cap, Vanguard Real...
May 22 / GuruFocus News - Paid Partner Content
Merck vs. Pfizer: Which Stock Looks Better Post Q1 Earnings?
May 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close61.84
Today’s open61.89
Day’s range61.89 - 62.72
Volume5,783,938
Average volume (3 months)6,795,040
Market cap$108.7B
Data as of 4:00pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)-71.18%
Earnings growth (this year)+14.60%
Earnings growth (next 5 years)+12.65%
Revenue growth (last year)+31.35%
P/E ratio297.7
Price/Sales3.64
Price/Book3.50

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.03+0.04%
NVONovo Nordisk-0.17-0.35%
BMYBristol-Myers Squibb+0.19+0.36%
GSKGlaxoSmithKline-0.15-0.37%
Data as of 4:02pm ET, 05/24/2018

Financials

Next reporting dateJuly 18, 2018
EPS forecast (this quarter)$0.71
Annual revenue (last year)$27.4B
Annual profit (last year)$468.0M
Net profit margin1.26%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian Bernard Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts